We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · October 29, 2020

Overall Survival Patients With Metastatic Melanoma Receiving Anticancer Drugs

Journal of Investigative Dermatology


Additional Info

Journal of Investigative Dermatology
Patients With Metastatic Melanoma Receiving Anticancer Drugs: Changes in Overall Survival, 2010–2017
J Invest Dermatol 2020 Oct 10;[EPub Ahead of Print], F Poizeau, S Kerbrat, A Happe, C Rault, E Drezen, F Balusson, P Tuppin, B Guillot, A Thuret, L Boussemart, M Dinulescu, M Pracht, T Lesimple, C Droitcourt, E Oger, A Dupuy

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading